Literature DB >> 25645854

Efficacy of postexposure therapy against glanders in mice.

David M Waag1.   

Abstract

Burkholderia mallei, the causative agent of glanders, is a CDC Tier 1 Select Agent for which there is no preventive vaccine and antibiotic therapy is difficult. In this study, we show that a combination of vaccination using killed cellular vaccine and therapy using moxifloxacin, azithromycin, or sulfamethoxazole-trimethoprim can protect BALB/c mice from lethal infection even when given 5 days after infectious challenge. Vaccination only, or antibiotic therapy only, was not efficacious. Although antibiotics evaluated experimentally can protect when given before or 1 day after challenge, this time course is not realistic in the cases of natural infection or biological attack, when the patient seeks treatment after symptoms develop or after a biological attack has been confirmed and the agent has been identified. Antibiotics can be efficacious after a prolonged interval between exposure and treatment, but only if the animals were previously vaccinated.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645854      PMCID: PMC4356808          DOI: 10.1128/AAC.04801-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Glanders in a military research microbiologist.

Authors:  A Srinivasan; C N Kraus; D DeShazer; P M Becker; J D Dick; L Spacek; J G Bartlett; W R Byrne; D L Thomas
Journal:  N Engl J Med       Date:  2001-07-26       Impact factor: 91.245

2.  In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test.

Authors:  H S Heine; M J England; D M Waag; W R Byrne
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.

Authors:  P Russell; S M Eley; J Ellis; M Green; D L Bell; D J Kenny; R W Titball
Journal:  J Antimicrob Chemother       Date:  2000-06       Impact factor: 5.790

4.  In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.

Authors:  D J Kenny; P Russell; D Rogers; S M Eley; R W Titball
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 5.  The zoonoses: an epidemiologist's viewpoint.

Authors:  J H Steele
Journal:  Prog Clin Pathol       Date:  1973

Review 6.  [Glanders (review)].

Authors:  G K Kovalev
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1971-01

7.  Laboratory-acquired human glanders--Maryland, May 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-06-23       Impact factor: 17.586

8.  Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice.

Authors:  Kei Amemiya; Gary V Bush; David DeShazer; David M Waag
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

9.  Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice.

Authors:  Chad J Roy; Martha Hale; Justin M Hartings; Louise Pitt; Steven Duniho
Journal:  Inhal Toxicol       Date:  2003-05       Impact factor: 2.724

10.  Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.

Authors:  Kay B Barnes; Jackie Steward; Joanne E Thwaite; M Stephen Lever; Carwyn H Davies; Stuart J Armstrong; Thomas R Laws; Neil Roughley; Sarah V Harding; Timothy P Atkins; Andrew J H Simpson; Helen S Atkins
Journal:  Int J Antimicrob Agents       Date:  2013-03-19       Impact factor: 5.283

View more
  3 in total

Review 1.  Emerging role of biologics for the treatment of melioidosis and glanders.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Alfredo G Torres
Journal:  Expert Opin Biol Ther       Date:  2019-10-15       Impact factor: 4.388

Review 2.  Innate immune response to Burkholderia mallei.

Authors:  Kamal U Saikh; Tiffany M Mott
Journal:  Curr Opin Infect Dis       Date:  2017-06       Impact factor: 4.915

3.  Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection.

Authors:  Marc Bayliss; Matthew I Donaldson; Sergey A Nepogodiev; Giulia Pergolizzi; Andrew E Scott; Nicholas J Harmer; Robert A Field; Joann L Prior
Journal:  Carbohydr Res       Date:  2017-09-21       Impact factor: 2.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.